SCHEMBL1934753

SCHEMBL1934753

O=C(O)Nc1cnccn1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.57
NPC1 O15118 5/20 0.57
KMT2A Q03164 4/20 0.56
KDM4E B2RXH2 5/20 0.53
TSHR P16473 1/20 0.51
TP53 P04637 1/20 0.51
MAPT P10636 1/20 0.51
NFKB1 P19838 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
GAA P10253 2/20 0.51
THRB P10828 1/20 0.50
NOTUM Q6P988 1/20 0.49
MEN1 O00255 1/20 0.49
POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30593991 1.00 RAB9A (0.57) RAB9ANPC1KMT2AKDM4ETSHR
SCHEMBL5381046 0.84 KDM4E (0.69) RAB9ANPC1KMT2AKDM4EMAPT
SCHEMBL20767994 0.81 RAB9A (0.49) RAB9ANPC1KMT2AKDM4ETSHR
SCHEMBL4208169 0.81 KMT2A (0.54) RAB9ANPC1KMT2AKDM4ETSHR
SCHEMBL4237518 0.81 RAB9A (0.56) RAB9ANPC1KMT2AKDM4ETSHR
SCHEMBL25097159 0.81 KMT2A (0.54) RAB9ANPC1KMT2AKDM4ETSHR
SCHEMBL4692505 0.81 KMT2A (0.54) RAB9ANPC1KMT2AKDM4ETSHR
SCHEMBL5139472 0.81 KMT2A (0.54) RAB9ANPC1KMT2AKDM4ETSHR
SCHEMBL9131695 0.79 KDM4E (0.46) RAB9ANPC1KMT2AKDM4ETSHR
SCHEMBL22950992 0.78 RAB9A (0.61) RAB9ANPC1KMT2AKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3983072-A1 PYRAZINE CARBAMATES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS Janssen Pharmaceutica NV (BE) 2022-04-20 EP disclosed
CN-113874074-A HMOX1 inducers 米托布里奇公司 2021-12-31 CN disclosed
CN-109641915-A Novel 4- (aryl)-N- (3- alkoxy furans simultaneously [2,3-B] pyrazine -2- base)-piperazine -1- carboxamides derivatives and its antiproliferative effect 东国大学校产学协力团 2019-04-16 CN disclosed
CN-105358151-B For treating the compound of Duchenne-Arandisease 豪夫迈·罗氏有限公司 2019-04-12 CN disclosed
CN-108774237-A New tricyclic compound ABBVIE 公司 2018-11-09 CN disclosed
CN-104370909-B Tricyclic compound ABBVIE 公司 2018-09-11 CN disclosed
CN-105358151-A Compounds for treating spinal muscular atrophy HOFFMANN LA ROCHE 2016-02-24 CN disclosed
CN-102264721-B Compounds useful as inhibitors of ATR kinase VERTEX PHARMACEUTICALS INC. (US) 2015-12-09 CN disclosed
CN-104370909-A Novel tricyclic compounds ABBOTT LAB 2015-02-25 CN disclosed
CN-102264721-A Compounds useful as inhibitors of ATR kinase 2011-11-30 CN disclosed
WO-2011068881-A1 NOVEL TRICYCLIC COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-09 WO disclosed
CN-1407973-A Butynediol Derivatives ACTELION PHARMACEUTICALS LTD (CH) 2003-04-02 CN disclosed
EP-0508469-B1 3,4,N-Trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insecticides DOWELANCO (US) 1999-03-03 EP disclosed
US-5493024-A 1,2-DIARYL-2-PROPEN-1-ONE CHEMICAL INTERMEDIATE COMPOUND DOWELANCO (US) 1996-02-20 US disclosed
US-5250532-A Moths. termites DOWELANCO (US) 1993-10-05 US disclosed
CN-1067426-A 3,4, N-three replaces-4,5-dihydro-1 h-pyrazole-1-methane amide and they application as sterilant DOWELANCO (US) 1992-12-30 CN disclosed
EP-0508469-A1 3,4,N-Trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insecticides DOWELANCO (US) 1992-10-14 EP disclosed